Stockreport

Progenics Pharmaceuticals stock soars 29% on news of positive results in prostate cancer drug trial [MarketWatch]

PROGENICS PHARMACEUTICALS  (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com
PDF Progenics Pharmaceuticals stock soars 29% on news of positive results in prostate cancer drug trial Progenics Pharmaceuticals, Inc. PGNX, -1.34% said Monday a late-st [Read more]